GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
US Stock MarketDetailed Quotes
ADCT ADC Therapeutics
- 1.770
- +0.010+0.57%
Close Jan 24 16:00 ET
- 1.770
- 0.0000.00%
Post 20:01 ET
171.14MMarket Cap-0.74P/E (TTM)
1.825High1.720Low363.93KVolume1.790Open1.760Pre Close644.78KTurnover0.47%Turnover RatioLossP/E (Static)96.69MShares6.04052wk High-1.00P/B136.00MFloat Cap1.66052wk Low--Dividend TTM76.83MShs Float56.590Historical High--Div YieldTTM5.97%Amplitude0.360Historical Low1.771Avg Price1Lot Size
About ADC Therapeutics Company
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Company Profile
SymbolADCT
Company NameADC Therapeutics
Listing DateMay 15, 2020
Issue Price19.00
Founded2011
CEOMr. Ameet Mallik
MarketNYSE
Employees274
Fiscal Year Ends12-31
AddressBiop?le,Route de la Corniche 3B
CityEpalinges
ProvinceVaud
CountrySwitzerland
Zip Code1066
Phone41-212-653-02-00
Company Executives
- Name
- Position
- Salary
- Ameet Mallik
- Chief Executive Officer and Director
- 3.78M
- Peter J. Graham
- Chief Legal Officer
- --
- Jose Carmona
- Chief Financial Officer
- 1.26M
- Mohamed Zaki, M.D.,PhD
- Chief Medical Officer
- 4.40M
- Lisa Michelle Kallebo
- Corporate Controller and Chief Accounting Officer
- --
- Ron Squarer
- Chairman of the Board
- 526.73K
- Thomas Pfisterer
- Director
- 194.30K
- Robert W. Azelby
- Independent Director
- 127.67K
- Dr. Victor Sandor, C.M.,M.D.
- Independent Director
- 227.72K
- Viviane Monges
- Independent Director
- 231.33K
- Dr. Tyrell J. Rivers, PhD
- Independent Director
- --
- Dr. Jean-Pierre Bizzari, M.D.
- Independent Director
- 197.81K
- Peter Hug, PhD
- Lead Independent Director
- 212.61K
Trending Stocks
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline?
Moomoo News Global
Dec 9, 2024 20:23
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011